Genetic Testing Market (By Type: Predictive Testing, Prenatal & Newborn Testing, Diagnostic Testing, Carrier Testing, Pharmacogenomic Testing, Others; By Technology: Biochemical Testing, Cytogenetic Testing/ Chromosome Analysis, Molecular Testing [DNA Sequencing, Others]; By Application: Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, Chromosome Analysis, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 190

According to Acumen Research and Consulting, the global Genetic Testing market is expected to grow at noteworthy CAGR around 11 % throughout the forecast period and reach around US$ 18 billion by 2026. The report provides analysis of global Genetic Testing market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.


The study of the gene in the cells and tissues is a genetic test. This study is used to further understand genetic disorders like cancer, sickle cell anemia, cystic fibrosis, downn syndrome and more. The report discusses the application of genetic tests for the development of individual medicine, the treatment of cancers and other genetic conditions. It furthermore highlights a variety of techniques including genomic hybridizing, hybridization, fluorescence in situ, karyotyping and others used for the detection of genetic malformations and cancer: the use of cytogenetic testing / chromosome analysis, biochemical trials, molecular testing and DNA sequencing. These techniques use products such as kits, media, reagent and others for genetic testing.

Market Dynamics

In the near future, the global market for genetic testing will increase substantially as genetic disorder and carcinogenic diseases increase and personalized medicinal products become increasingly aware of their acceptance. Moreover, progress in genetic testing techniques and the increasing use of genetic oncology testing will boost market growth over the predictive period. However, standardization concerns for genetic testing-based diagnoses and stringent product approval regulatory requirements are anticipated during the prediction period to interfere with the growth of the genetic test market. In contrast, untapped emerging markets are expected to offer market players payment opportunities in developing countries. These factors are therefore expected to increase global market share for genetic testing.

Type, technology, application and region are the basis of the international genetic testing industry. The market is classified by type into predictive tests, predictive tests, preventive and neonatal tests, diagnostic tests, pharmacogenomic tests and so on. The market is split into cytogenetic tests, DNA sequencing, molecular testing and DNA sequencing on the basis of technology. It is segmented into cancer diagnosis, diagnosis of genetic conditions, diagnosis of cardiovascular diseases and others by application. The market in North America, Europe, Asia-Pacific and LAMEA is analyzed regionally.

Market Insights

Due to increasing awareness about the same and increasing investment in this field, molecular diagnosis market is growing at a significant rate. Genetic testing refers to a human DNA analysis process in any form of human DNA, or associated products such as RNA, chromosomes, DNA, etc. Genetic testing is widely employed in the detection of genotype, phenotype or mutation-related diseases. Genetic trials are also performed for clinical purposes to detect karyotype. Due to the various advantages offered by this procedure, such as detected genetic abnormality in early gestation about 8 to 10 weeks, the popularity of genetic testing is increasing. It also helps to establish the sex of the fetus. Due to increased awareness and findings of this field, the genetic testing market is growing at a significant rate. The genetic mutations screening with the trans-membrane conductance regulator gene (CFTR) of the Cystic Fibrosis gene is most common among all the tests conducted for genetic testing.

Type Outlook

The market is divided into prenatal, newborn and prenatal tests, testing, pharmacogenomic tests and others, according to type. The diagnostic test segment is currently leading with turnover in 2018 and its dominance is projected to remain over the forecast period. This is due to the increase in human sensitivity to health and increased mortality incidences due to genetic diseases worldwide. On the other hand, during the forecast period, the pharmacogenomic test segment is expected to be the most highly effective CAGR. This is largely because pharmaceutical companies are making increasing use of drugs discovery and development.

Application Stance

The genetic test market is divided into chromosome analysis, genetic disease diagnosis, diagnosis of cardiovascular conditions and others, depending on the application. During the forecast period, the segment of diagnostic cardiovascular diseases is expected to show most growth. This is attributed to an increasing rate of mortality as a result of legacy cardiomyopathy, hypertrophic cardiomyopathy (HCM), expanded cardiomyopathy (DCM) and others caused by one or very little genetic changes. In the near future it therefore helps to increase the market size for genetic testing.

Regional Stance

The genetic testing market was dominated by North America with sales of US$ 6 billion in 2018 and is projected to grow substantially over the forecast period. This is because genetic disorders, like cancer, Turner syndrome, neurofibromatosis and spinal muscle atrophy are increasing. The provision of new tests will fuel the demand for genetic testing due to technological developments. In the coming years, further market growth will be strengthened by advanced infrastructure, combined with high healthcare and regulatory support for direct-to-consumer genetic testing. Due to increasing prevalence of different types of cancer, including prostate, breast, and lung cancer, the Latin America Genetic Test Market is expected to grow in a robust CAGR of around 13 percent during the forecasting period. In Latin America, breast cancer is the most prevalent cancer in females. Breast cancer is estimated to increase by 46% by 2030, according to the Pan American Health Organization (PAHO). The number of breast cancer women is estimated in around 4.08.200. Accelerating regional growth over the forecast period will thus be implemented by genetic tests for the early detection and prevention of cancer and other genetic conditions.

Market Segmentation

Global Genetic Testing Market, by Type

  • Predictive Testing
  • Prenatal & Newborn Testing
  • Diagnostic Testing
  • Carrier Testing
  • Pharmacogenomic Testing
  • Others

Global Genetic Testing Market, by Technology

  • Biochemical Testing
  • Cytogenetic Testing/ Chromosome Analysis
  • Molecular Testing
    • DNA Sequencing
    • Others

Global Genetic Testing Market, by Application

  • Genetic Disease Diagnosis
  • Cardiovascular Disease Diagnosis
  • Chromosome Analysis
  • Others

Global Genetic Testing Market, by Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

The market research study on “Genetic Testing Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Genetic Testing market segments with market dynamics and their impact. The report also covers basic technology development policies.

The global market for genetic testing is driven by a range of factors, such as progress in genetic testing, an ever greater prevalence of genetic diseases and an increase in awareness. In addition, the market for genetic testing was driven by government initiatives and increased R&D activity in the field. However, the world market in genetic testing is restricted by high costs, the lack of skilled professionals and stringent regulations in some regions.

Key Players & Strategies

23andMe, Abbott Molecular, Biocartis, BioHelix, Bayer Diagnostics, BioMerieux, BGI, Celera Genomics, Cepheid, Counsyl, deCODEme, Genentech, Genomictree, HTG Molecular Diagnostics, Luminex, MolecularMD, IntegraGen, LabCorp diagnostics, Myriad, Natera, PacBio, Pathway Genomics, Qiagen, Roche Diagnostic is among the most eminent players in the global genetic testing market. Industry players focus on the strategic expansion of their product portfolio through acquisitions, fusions and collaborations. Roche, for example, in December 2018, acquired the Non-invasive Prenatal (NIPT) and cell-free DNA testing services market Ariosa Diagnostics, a provider of molecular diagnostic testing services.

The increasing prevalence in the genetic testing industry will drive a growing global genetic testing industry for diseases like cancer, cystic fibrosis, Alzheimer's and others. Increasing genetical tests and genetic mutation identification before their onset will further increase the industry's growth over the forecast period. Due to the increased adoption of genetic testing by physicians in clinical care, the industry should see rapid growth in future. The availability of direct consumer (DTC) regulatory aid and on-going technological advances allow industry players to maintain a position on the market.

Related Reports

Electronic Drug Delivery Systems Market By Product (Electronic Wearable Infusion Pumps, Electronic Injection Pens, Electronic Inhalers, Autoinjectors), By Indication (Diabetes, Cardiovascular Diseases, Multiple Sclerosis, COPD & Asthma) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global electronic drug delivery systems market size is expected to reach around US$ 12.1 billion by 2026 and growing at a CAGR of around 8.9% from forecast period 2019 to 2026. Electronic drug delivery systems are smart devices that allow the patient to administer medicines in small quantities. These devices add value to traditional and non-automated devices and thereby improve the ease of administration, convenience, and portability.

Long Term Care Market By Service: ( Home Healthcare, Hospice, Nursing Care, Assisted Living Facilities ) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global long term care market size is expected to reach around 1,621 Mn by 2026 and growing at a CAGR of around 7% over the forecast period 2019 to 2026. Long term care is a term used for a variety of services, which are specially designed to meet a person's short term and long term requirement for health and personal care. This is also termed as Activities of Daily Living or ADLs, when it is served for personal care, such as dressing,

Precision Medicine Market By Technology: (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Others); By Application: (Oncology, Immunology, CNS, Respiratory); By End Use: (Home care, Hospitals, Clinical Laboratories, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global precision medicine market size is expected to reach around US$ 84 Bn by 2026 and is anticipated to grow at a CAGR of around 10% in terms of revenue during the forecast period 2019 to 2026. Precision medicine is an approach to patient care that enables physicians to choose medicines that assist patients to understand their disease genetically. This can also be called custom medicine. The report provides analysis of global precis

Comprehensive Metabolic Panel (CMP) Testing Market By Disease: (Kidney Disease, Liver Disease, Diabetes, Others); By Test Type: (Proteins, Electrolytes, Kidney Tests, Liver Functional Tests, Glucose); By End-Use: (Laboratories, PoC) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The Global Comprehensive Metabolic Panel (CMP) Testing Market size is expected to reach over US$ 18,380 Mn by 2026 and growing at a CAGR of around 7.0% from 2019 to 2026. The Comprehensive Metabolic Panel (CMP) is a commonly ordered set of 14 tests that give doctor a significant data about the present status of kidneys, electrolyte, liver and acid / base balance as well as blood sugar and blood proteins. Abnormal findings, and in particular abnormal resul

Recreational Oxygen Equipment Market By Product: Concentrators, Bar Equipment, others; By Application: Athletics/Sports, Medical, others - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global recreational oxygen equipment market is expected to grow at a CAGR of around 16.3% from 2019 to 2026 and reach the market value of around 307 Mn by 2026. Recreational Oxygen is also termed as consumer oxygen, which is used to enhance brain functioning and also to improve athletic endurance. Recreational oxygen can’t be replaced with the medical oxygen as medical oxygen is used for treatment purposes and is controlled by the FDA as a thera

Plasmid DNA Manufacturing Market (By Application: Gene Therapy, Vaccinology; By Disease: Infectious Disease, Cancer, Genetic Disorder: Research Institute , Biotech Companies; By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global plasmid DNA manufacturing market size is expected to reach over US$ 300 million by 2026 and growing at a CAGR of 20% from forecast period 2019 to 2026. There are continuous development activities carried by major players in order to test plasmid DNA applicability. Usually plasmid DNA is prepared by cesium chloride density ultracentrifugation process and it has wide applications such as c

Cart Summary